Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Houston Thompson

Showing results (101-110 of 374) with videos related to

Pageof 38
Sort By:
The Journal of Urology|September 25, 2012
Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classificationsShabnam Zarei, Igor Frank, Stephen A Boorjian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2012
ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patientsWilliam R Sukov, Jennelle C Hodge, Christine M Lohse, et al.
The Journal of Urology|July 17, 2007
Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen eraStephen A Boorjian, R Houston Thompson, Sameer Siddiqui, et al.
European Urology|March 11, 2011
Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrenceStephen A Boorjian, R Houston Thompson, Matthew K Tollefson, et al.
European Urology|April 26, 2011
Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal glandChristopher J Weight, Simon P Kim, Christine M Lohse, et al.
BJU International|April 5, 2013
Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-upBen Y Zhang, R Houston Thompson, Christine M Lohse, et al.
Urology|April 30, 2016
Risk Factors and Microbial Distribution of Urinary Tract Infections Following Radical CystectomyWilliam P Parker, Amir Toussi, Matthew K Tollefson, et al.
BJU International|January 30, 2014
The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC)Brian J Linder, R Houston Thompson, Bradley C Leibovich, et al.
BJU International|August 17, 2018
Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinomaParas H Shah, Timothy D Lyon, Christine M Lohse, et al.
Urologic Oncology|December 13, 2016
Patient factors associated with 30-day complications after partial nephrectomy: A contemporary updateHarras B Zaid, William P Parker, Christine M Lohse, et al.
Pageof 38

Showing results (101-110 of 374) with videos related to

Sort By:
Pageof 38
The Journal of Urology|September 25, 2012
Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classificationsShabnam Zarei, Igor Frank, Stephen A Boorjian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2012
ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patientsWilliam R Sukov, Jennelle C Hodge, Christine M Lohse, et al.
The Journal of Urology|July 17, 2007
Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen eraStephen A Boorjian, R Houston Thompson, Sameer Siddiqui, et al.
European Urology|March 11, 2011
Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrenceStephen A Boorjian, R Houston Thompson, Matthew K Tollefson, et al.
European Urology|April 26, 2011
Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal glandChristopher J Weight, Simon P Kim, Christine M Lohse, et al.
BJU International|April 5, 2013
Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-upBen Y Zhang, R Houston Thompson, Christine M Lohse, et al.
Urology|April 30, 2016
Risk Factors and Microbial Distribution of Urinary Tract Infections Following Radical CystectomyWilliam P Parker, Amir Toussi, Matthew K Tollefson, et al.
BJU International|January 30, 2014
The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC)Brian J Linder, R Houston Thompson, Bradley C Leibovich, et al.
BJU International|August 17, 2018
Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinomaParas H Shah, Timothy D Lyon, Christine M Lohse, et al.
Urologic Oncology|December 13, 2016
Patient factors associated with 30-day complications after partial nephrectomy: A contemporary updateHarras B Zaid, William P Parker, Christine M Lohse, et al.
Pageof 38